Are protein substitutes available in Italy for infants with inherited metabolic diseases all the same?
This study represents the first comprehensive comparison of the nutritional profiles of IPSs for IMDs on the Italian market. The results identify potential areas for optimization, aiming to provide adequate levels of micronutrients, essential fatty acids, and functional ingredients, such as biotics, to support gut health, immune function, and neurodevelopment.
Authors
- Margherita Di Costanzo (ORCID: https://orcid.org/0000-0002-8985-770X)
- Martina Tosi (ORCID: https://orcid.org/0000-0003-0053-0098)
- Elvira Verduci (ORCID: https://orcid.org/0000-0003-2111-3111)
- Giacomo Biasucci (ORCID: https://orcid.org/0000-0002-7441-9248)
- Enrico Vito Buono
- Simone Bruni
- Martina Muzi
- Valentina D’Onghia
- Anna Munerati
- Gabriele Tarditi
Institutions
- University of Parma (IT)
- University of Milan (IT)
- Guglielmo da Saliceto Hospital (IT)
- Ospedale dei Bambini Vittore Buzzi (IT)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2025-05-26
- DOI
- https://doi.org/10.3389/fnut.2025.1581295
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00